Two new studies boost evidence for the bioavailability and efficacy of Xangold(R) natural lutein esters

Two new studies boost evidence for the bioavailability and efficacy of Xangold(R) natural lutein esters In his presentation at the Vitafoods International Supplier Seminar Theatre today (Wednesday, May 9), Holger Becker, Ph.D., cited two new studies which strengthen existing scientific evidence on the bioavailability and efficacy of Xangoldâ natural lutein esters.
Home Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P. Natrol Appoints Vincent Andrich VP Sales for Prolab Division Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results Body Shop Reports 24.8 Mil Euro Sales Revenues Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label Supplement Group Targets Consumer Education Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO drugstore.com Expects to Reach Profitability Target in 2003 Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway Natural Health Trends Corp. Launches Lexxus Taiwan FDA Presents Compliance Guide for Structure/Function Claims New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids Cyanotech Names Bob Capelli as Director of Sales Bioiberica responds to recently published Chondroitin Sulfate meta-analysis. Dr. Sukh Bassi Named VP of Scientific Affairs at MGP Ingredients Sukh Bassi, Ph.D., has been appointed to the newly created position of vice president of scientific affairs at MGP Ingredients, Inc. Dr. Sukh Bassi Named VP of Scientific Affairs at MGP Ingredients Sukh Bassi, Ph.D., has been appointed to the newly created position of vice president of scientific affairs at MGP Ingredients, Inc. Dr. Sukh Bassi Named VP of Scientific Affairs at MGP Ingredients Sukh Bassi, Ph.D., has been appointed to the newly created position of vice president of scientific affairs at MGP Ingredients, Inc. Dr. Sukh Bassi Named VP of Scientific Affairs at MGP Ingredients Sukh Bassi, Ph.D., has been appointed to the newly created position of vice president of scientific affairs at MGP Ingredients, Inc. AHPA Challenges Kelp Product Case Report The American Herbal Products Association (AHPA) has countered a recently published case report that concluded that a kelp supplement may have caused arsenic poisoning. In a letter to the editor submitted to the publishing journal, AHPA notes that the subject had ignored a specific label caution and suggested that iodine overdose was no less plausible an explanation for the observed symptoms. AHPA Challenges Kelp Product Case Report The American Herbal Products Association (AHPA) has countered a recently published case report that concluded that a kelp supplement may have caused arsenic poisoning. In a letter to the editor submitted to the publishing journal, AHPA notes that the subject had ignored a specific label caution and suggested that iodine overdose was no less plausible an explanation for the observed symptoms. Allimax Nutraceuticals Updates Lyme Disease Study Data Company presents newly completed blood work on its LYME clinical study participants. Allimax Nutraceuticals Updates Lyme Disease Study Data Company presents newly completed blood work on its LYME clinical study participants. Study: Vegapure® Plant Sterol Esters in Capsule Form Significantly Reduce LDL Cholesterol Without Dietary Intervention The first published human study to confirm that regular use of plant sterol esters capsules are effective in improving lipid profiles without dietary intervention appears online in the current issue of Lipids in Health and Disease (Lipids Health Dis. 2007, Apr 9; 6(1):11 [Epub]). Study: Vegapure® Plant Sterol Esters in Capsule Form Significantly Reduce LDL Cholesterol Without Dietary Intervention The first published human study to confirm that regular use of plant sterol esters capsules are effective in improving lipid profiles without dietary intervention appears online in the current issue of Lipids in Health and Disease (Lipids Health Dis. 2007, Apr 9; 6(1):11 [Epub]). Study: Vegapure® Plant Sterol Esters in Capsule Form Significantly Reduce LDL Cholesterol Without Dietary Intervention The first published human study to confirm that regular use of plant sterol esters capsules are effective in improving lipid profiles without dietary intervention appears online in the current issue of Lipids in Health and Disease (Lipids Health Dis. 2007, Apr 9; 6(1):11 [Epub]). Study: Vegapure® Plant Sterol Esters in Capsule Form Significantly Reduce LDL Cholesterol Without Dietary Intervention The first published human study to confirm that regular use of plant sterol esters capsules are effective in improving lipid profiles without dietary intervention appears online in the current issue of Lipids in Health and Disease (Lipids Health Dis. 2007, Apr 9; 6(1):11 [Epub]). Study: Vegapure® Plant Sterol Esters in Capsule Form Significantly Reduce LDL Cholesterol Without Dietary Intervention The first published human study to confirm that regular use of plant sterol esters capsules are effective in improving lipid profiles without dietary intervention appears online in the current issue of Lipids in Health and Disease (Lipids Health Dis. 2007, Apr 9; 6(1):11 [Epub]). Nordic Phytopharma builds science on potent immune booster IMMULINA™, with its most recent clinical data, and COLDIZIN® will be presented to the nutraceutical industry at the Finished Products exhibition at Vitafoods in Geneva. Nordic Phytopharma builds science on potent immune booster IMMULINA™, with its most recent clinical data, and COLDIZIN® will be presented to the nutraceutical industry at the Finished Products exhibition at Vitafoods in Geneva. Nordic Phytopharma builds science on potent immune booster IMMULINA™, with its most recent clinical data, and COLDIZIN® will be presented to the nutraceutical industry at the Finished Products exhibition at Vitafoods in Geneva. Next Pharmaceuticals Examines Nexrutine® Effect on Prostate Cancer Progression in Pre-clinical Animal Model The results of an animal study, published in Clinical Cancer Research, indicate that that an over-the-counter non-toxic botanical supplement, Nexrutine (Phellodendron amurense), prevents the progression of prostate tumors in mice. Next Pharmaceuticals Examines Nexrutine® Effect on Prostate Cancer Progression in Pre-clinical Animal Model The results of an animal study, published in Clinical Cancer Research, indicate that that an over-the-counter non-toxic botanical supplement, Nexrutine (Phellodendron amurense), prevents the progression of prostate tumors in mice. EPAX Expands Purity Standards Leading Omega-3 Supplier's Purity Standards Now Include Oxidation Parameters, in Addition to Lowering Acceptance Levels of Dioxins, Furans and PCBs EPAX Expands Purity Standards Leading Omega-3 Supplier's Purity Standards Now Include Oxidation Parameters, in Addition to Lowering Acceptance Levels of Dioxins, Furans and PCBs First Carbonated Beverage Line Certified 'Glycemic Index Tested' The Organic Beverage Company, announced the successful completion of human clinical trials establishing the very first carbonated beverage line to be certified as Glycemic Index Tested. First Carbonated Beverage Line Certified 'Glycemic Index Tested' The Organic Beverage Company, announced the successful completion of human clinical trials establishing the very first carbonated beverage line to be certified as Glycemic Index Tested. Scientific Research Community Challenged to Consider Broader Spectrum Of Research Beyond RCTs For Studying Nutrition At a May 3 scientific symposium, The Workshop, presented by the Council for Responsible Nutrition (CRN), the trade association’s President and CEO Steve Mister challenged the audience of scientists to consider whether the drug model for scientific research—relying strictly on randomized clinical trials (RCTs) and evidence-based medicine (EBM)—is the most appropriate research model for nutrients, including dietary supplements. Scientific Research Community Challenged to Consider Broader Spectrum Of Research Beyond RCTs For Studying Nutrition At a May 3 scientific symposium, The Workshop, presented by the Council for Responsible Nutrition (CRN), the trade association’s President and CEO Steve Mister challenged the audience of scientists to consider whether the drug model for scientific research—relying strictly on randomized clinical trials (RCTs) and evidence-based medicine (EBM)—is the most appropriate research model for nutrients, including dietary supplements. New study shows that a daily supplement of 12 mg lutein from Xangold(R) natural lutein esters increases macular pigment density in adults with early-stage AMD Study published in the April edition of Experimental Eye Research involved 108 adults who received a daily supplement containing antioxidants - including 12 mg lutein from Xangold(R) lutein esters - for six months and a contro, groupo who recevied no supplements. Results in the intervention group showed substantial increases in blood levels of lutein and a statistically significant average increase of 16% in macular pigment density. New study shows that a daily supplement of 12 mg lutein from Xangold(R) natural lutein esters increases macular pigment density in adults with early-stage AMD Study published in the April edition of Experimental Eye Research involved 108 adults who received a daily supplement containing antioxidants - including 12 mg lutein from Xangold(R) lutein esters - for six months and a contro, groupo who recevied no supplements. Results in the intervention group showed substantial increases in blood levels of lutein and a statistically significant average increase of 16% in macular pigment density. New study shows that a daily supplement of 12 mg lutein from Xangold(R) natural lutein esters increases macular pigment density in adults with early-stage AMD Study published in the April edition of Experimental Eye Research involved 108 adults who received a daily supplement containing antioxidants - including 12 mg lutein from Xangold(R) lutein esters - for six months and a contro, groupo who recevied no supplements. Results in the intervention group showed substantial increases in blood levels of lutein and a statistically significant average increase of 16% in macular pigment density. Dr. John P. Vasilakos Joins Biothera as Vice President, Immunology John P. Vasilakos, Ph.D., has joined Biothera as vice president of Immunology, with responsibility for biology/immunology research, including management of the company’s research collaborations. Dr. John P. Vasilakos Joins Biothera as Vice President, Immunology John P. Vasilakos, Ph.D., has joined Biothera as vice president of Immunology, with responsibility for biology/immunology research, including management of the company’s research collaborations. Dr. John P. Vasilakos Joins Biothera as Vice President, Immunology John P. Vasilakos, Ph.D., has joined Biothera as vice president of Immunology, with responsibility for biology/immunology research, including management of the company’s research collaborations. Dr. John P. Vasilakos Joins Biothera as Vice President, Immunology John P. Vasilakos, Ph.D., has joined Biothera as vice president of Immunology, with responsibility for biology/immunology research, including management of the company’s research collaborations. Study Finds Biothera Compounds Enhance Human Immune Cell Function Researchers at Rhode Island Hospital and the Warren Alpert Medical School at Brown University measured the ability of human neutrophils to kill filamentous Candida albicans, determining that Biothera’s yeast-derived beta 1,3/1,6 glucans (Imprime PGG(TM) and WGP(R) 3-6) enhance the anti-microbial function of the neutrophils. Study Finds Biothera Compounds Enhance Human Immune Cell Function Researchers at Rhode Island Hospital and the Warren Alpert Medical School at Brown University measured the ability of human neutrophils to kill filamentous Candida albicans, determining that Biothera’s yeast-derived beta 1,3/1,6 glucans (Imprime PGG(TM) and WGP(R) 3-6) enhance the anti-microbial function of the neutrophils. Study Finds Biothera Compounds Enhance Human Immune Cell Function Researchers at Rhode Island Hospital and the Warren Alpert Medical School at Brown University measured the ability of human neutrophils to kill filamentous Candida albicans, determining that Biothera’s yeast-derived beta 1,3/1,6 glucans (Imprime PGG(TM) and WGP(R) 3-6) enhance the anti-microbial function of the neutrophils. Enzymotec Presents Successful Trial Findings Enzymotec' study on the effect of Sharp-PS(TM) PLATINUM on over 60 ADHD schoolchildren, was presented at the 2007 Annual Meeting of the Pediatric Academic Societies (PAS), in Toronto. Enzymotec Presents Successful Trial Findings Enzymotec' study on the effect of Sharp-PS(TM) PLATINUM on over 60 ADHD schoolchildren, was presented at the 2007 Annual Meeting of the Pediatric Academic Societies (PAS), in Toronto. Enzymotec Presents Successful Trial Findings Enzymotec' study on the effect of Sharp-PS(TM) PLATINUM on over 60 ADHD schoolchildren, was presented at the 2007 Annual Meeting of the Pediatric Academic Societies (PAS), in Toronto. New Clinical Study In Baby Boomer and Older Health and Fitness Club Members Improvements in cognitive ability and physical fitness were seen in the vast majority of participants who participated in eight-week clinical trial. New Clinical Study In Baby Boomer and Older Health and Fitness Club Members Improvements in cognitive ability and physical fitness were seen in the vast majority of participants who participated in eight-week clinical trial. New Clinical Study In Baby Boomer and Older Health and Fitness Club Members Improvements in cognitive ability and physical fitness were seen in the vast majority of participants who participated in eight-week clinical trial. INTER FARMA's response to the "Meta-analysis: Chondroitin for Osteoarthritis of the Knee or Hip" Ibter-Farma and Dr. Jose N. Racca MD, MSc, PhD comment on the april 17, 2007 Annals of Internal Medicine article. (Volume 146, Issue 8, Pages 580 to 590.) INTER FARMA's response to the "Meta-analysis: Chondroitin for Osteoarthritis of the Knee or Hip" Ibter-Farma and Dr. Jose N. Racca MD, MSc, PhD comment on the april 17, 2007 Annals of Internal Medicine article. (Volume 146, Issue 8, Pages 580 to 590.) INTER FARMA's response to the "Meta-analysis: Chondroitin for Osteoarthritis of the Knee or Hip" Ibter-Farma and Dr. Jose N. Racca MD, MSc, PhD comment on the april 17, 2007 Annals of Internal Medicine article. (Volume 146, Issue 8, Pages 580 to 590.) INTER FARMA's response to the "Meta-analysis: Chondroitin for Osteoarthritis of the Knee or Hip" Ibter-Farma and Dr. Jose N. Racca MD, MSc, PhD comment on the april 17, 2007 Annals of Internal Medicine article. (Volume 146, Issue 8, Pages 580 to 590.) Calcium, Vitamin D Supplements May Help Prevent Weight Gain in Postmenopausal Women A report featured in the May 14, 2007 edition of Archives of Internal Medicine evaluated 36,282 postmenopausal women ages 50 to 79 years who were enrolled in the Women's Health Initiative clinical trial, observing that those who took daily calcium and vitamin D supplements over a seven-year period weighed an average 0.28 pounds less, and were less likely to gain weight than women who received placebos. Calcium, Vitamin D Supplements May Help Prevent Weight Gain in Postmenopausal Women A report featured in the May 14, 2007 edition of Archives of Internal Medicine evaluated 36,282 postmenopausal women ages 50 to 79 years who were enrolled in the Women's Health Initiative clinical trial, observing that those who took daily calcium and vitamin D supplements over a seven-year period weighed an average 0.28 pounds less, and were less likely to gain weight than women who received placebos. Calcium, Vitamin D Supplements May Help Prevent Weight Gain in Postmenopausal Women A report featured in the May 14, 2007 edition of Archives of Internal Medicine evaluated 36,282 postmenopausal women ages 50 to 79 years who were enrolled in the Women's Health Initiative clinical trial, observing that those who took daily calcium and vitamin D supplements over a seven-year period weighed an average 0.28 pounds less, and were less likely to gain weight than women who received placebos. Calcium, Vitamin D Supplements May Help Prevent Weight Gain in Postmenopausal Women A report featured in the May 14, 2007 edition of Archives of Internal Medicine evaluated 36,282 postmenopausal women ages 50 to 79 years who were enrolled in the Women's Health Initiative clinical trial, observing that those who took daily calcium and vitamin D supplements over a seven-year period weighed an average 0.28 pounds less, and were less likely to gain weight than women who received placebos. Calcium, Vitamin D Supplements May Help Prevent Weight Gain in Postmenopausal Women A report featured in the May 14, 2007 edition of Archives of Internal Medicine evaluated 36,282 postmenopausal women ages 50 to 79 years who were enrolled in the Women's Health Initiative clinical trial, observing that those who took daily calcium and vitamin D supplements over a seven-year period weighed an average 0.28 pounds less, and were less likely to gain weight than women who received placebos. Calcium, Vitamin D Supplements May Help Prevent Weight Gain in Postmenopausal Women A report featured in the May 14, 2007 edition of Archives of Internal Medicine evaluated 36,282 postmenopausal women ages 50 to 79 years who were enrolled in the Women's Health Initiative clinical trial, observing that those who took daily calcium and vitamin D supplements over a seven-year period weighed an average 0.28 pounds less, and were less likely to gain weight than women who received placebos. Higher intake of fish and vitamin D levels linked to lower risk of age-related macular disease Two reports in the May issue of Archives of Ophthalmology indicate that Individuals who have higher dietary intake of foods with omega-3 fatty acids and higher fish consumption have a reduced risk of advanced age-related macular degeneration, while those with higher serum levels of vitamin D may have a reduced risk of the early stages of the disease. Higher intake of fish and vitamin D levels linked to lower risk of age-related macular disease Two reports in the May issue of Archives of Ophthalmology indicate that Individuals who have higher dietary intake of foods with omega-3 fatty acids and higher fish consumption have a reduced risk of advanced age-related macular degeneration, while those with higher serum levels of vitamin D may have a reduced risk of the early stages of the disease. Higher intake of fish and vitamin D levels linked to lower risk of age-related macular disease Two reports in the May issue of Archives of Ophthalmology indicate that Individuals who have higher dietary intake of foods with omega-3 fatty acids and higher fish consumption have a reduced risk of advanced age-related macular degeneration, while those with higher serum levels of vitamin D may have a reduced risk of the early stages of the disease. Higher intake of fish and vitamin D levels linked to lower risk of age-related macular disease Two reports in the May issue of Archives of Ophthalmology indicate that Individuals who have higher dietary intake of foods with omega-3 fatty acids and higher fish consumption have a reduced risk of advanced age-related macular degeneration, while those with higher serum levels of vitamin D may have a reduced risk of the early stages of the disease. Higher intake of fish and vitamin D levels linked to lower risk of age-related macular disease Two reports in the May issue of Archives of Ophthalmology indicate that Individuals who have higher dietary intake of foods with omega-3 fatty acids and higher fish consumption have a reduced risk of advanced age-related macular degeneration, while those with higher serum levels of vitamin D may have a reduced risk of the early stages of the disease. Study shows that grapes may slow the progression of Type I Autoimmune Diabetes in lab mice A new study appearing in the current issue of the peer-reviewed Journal of Nutrition(1) shows that consuming grapes protected against the destruction of insulin-producing cells (known as beta cells) in the pancreas, significantly reducing the incidence of diabetes in lab rodents. Study shows that grapes may slow the progression of Type I Autoimmune Diabetes in lab mice A new study appearing in the current issue of the peer-reviewed Journal of Nutrition(1) shows that consuming grapes protected against the destruction of insulin-producing cells (known as beta cells) in the pancreas, significantly reducing the incidence of diabetes in lab rodents. Natural Products Association Questions Conclusions of New Study on Multivitamins and Prostate Cancer In comments from Daniel Fabricant, Ph.D., vice president of scientific and regulatory affairs, the Natural Products Association challenged findings to be published in the May 16, 2007 issue of the Journal of the National Cancer Institute regarding an association between multivitamin use and increased risk of prostate cancer. Natural Products Association Questions Conclusions of New Study on Multivitamins and Prostate Cancer In comments from Daniel Fabricant, Ph.D., vice president of scientific and regulatory affairs, the Natural Products Association challenged findings to be published in the May 16, 2007 issue of the Journal of the National Cancer Institute regarding an association between multivitamin use and increased risk of prostate cancer. Natural Products Association Questions Conclusions of New Study on Multivitamins and Prostate Cancer In comments from Daniel Fabricant, Ph.D., vice president of scientific and regulatory affairs, the Natural Products Association challenged findings to be published in the May 16, 2007 issue of the Journal of the National Cancer Institute regarding an association between multivitamin use and increased risk of prostate cancer. Natural Products Association Questions Conclusions of New Study on Multivitamins and Prostate Cancer In comments from Daniel Fabricant, Ph.D., vice president of scientific and regulatory affairs, the Natural Products Association challenged findings to be published in the May 16, 2007 issue of the Journal of the National Cancer Institute regarding an association between multivitamin use and increased risk of prostate cancer. Natural Products Association Questions Conclusions of New Study on Multivitamins and Prostate Cancer In comments from Daniel Fabricant, Ph.D., vice president of scientific and regulatory affairs, the Natural Products Association challenged findings to be published in the May 16, 2007 issue of the Journal of the National Cancer Institute regarding an association between multivitamin use and increased risk of prostate cancer. Study: Glucosamine-like supplement inhibits multiple sclerosis, type-1 diabetes According to University of California, Irvine health sciences researchers, a glucosamine-like dietary supplement (N-acetylglucosamine (GlcNAc)) has been found to suppress the damaging autoimmune response seen in multiple sclerosis and type-1 diabetes mellitus in mice. The study results appear on the online version of the Journal of Biological Chemistry. Study: Glucosamine-like supplement inhibits multiple sclerosis, type-1 diabetes According to University of California, Irvine health sciences researchers, a glucosamine-like dietary supplement (N-acetylglucosamine (GlcNAc)) has been found to suppress the damaging autoimmune response seen in multiple sclerosis and type-1 diabetes mellitus in mice. The study results appear on the online version of the Journal of Biological Chemistry. New Mouse Study Indicates That Pine Bark Counteracts "Wearing Out" Of the Heart A mouse study to be published in an upcoming edition of the journal of Cardiovascular Toxicology reveals Pycnogenol(r), natural pine bark extract from the French maritime pine tree, helps prevent damage that high blood pressure causes to the heart. New Mouse Study Indicates That Pine Bark Counteracts "Wearing Out" Of the Heart A mouse study to be published in an upcoming edition of the journal of Cardiovascular Toxicology reveals Pycnogenol(r), natural pine bark extract from the French maritime pine tree, helps prevent damage that high blood pressure causes to the heart. New Mouse Study Indicates That Pine Bark Counteracts "Wearing Out" Of the Heart A mouse study to be published in an upcoming edition of the journal of Cardiovascular Toxicology reveals Pycnogenol(r), natural pine bark extract from the French maritime pine tree, helps prevent damage that high blood pressure causes to the heart. Harvard Men’s Health Watch: Red wine protects the prostate Researchers in Seattle collected information about many factors that might influence the risk of prostate cancer in men between ages 40 and 64, including alcohol consumption, determining that men who drink an average of four to seven glasses of red wine per week are only 52% as likely to be diagnosed with prostate cancer as those who do not drink red wine. Harvard Men’s Health Watch: Red wine protects the prostate Researchers in Seattle collected information about many factors that might influence the risk of prostate cancer in men between ages 40 and 64, including alcohol consumption, determining that men who drink an average of four to seven glasses of red wine per week are only 52% as likely to be diagnosed with prostate cancer as those who do not drink red wine. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Another Reason to Choose Healthy Lifestyle Habits Another Reason to Choose Healthy Lifestyle Habits	For a health ingredient to be effective it must first be absorbed by the body and then be shown to produce a benefit. In his presentation at the Vitafoods International Supplier Seminar Theatre today (Wednesday, May 9), Holger Becker, Ph.D., cited two new studies which strengthen existing scientific evidence on the bioavailability and efficacy of Xangoldâ natural lutein esters. Previously published research has shown that lutein from lutein esters is well absorbed by the body and that esterification does not impair lutein bioavailability in humans. The first study presented by Dr. Becker, Global Product Line Manager for Xangoldâ, demonstrates why this might be the case. “We know that the body digests and absorbs fat-soluble dietary compounds -- like lutein esters -- as part of the normal, multi-stage digestive process”, said Dr. Becker. “Lutein esters are broken apart, releasing the ‘free’ lutein for absorption into the bloodstream. New research by Peter Molnar suggests that this multi-stage process – which some have suggested can impair bioavailability of compounds in ester form – may in fact, do the opposite”, he said. The research led by Dr Molnar, from the Department of Biochemistry and Medical Chemistry, University of Pécs in Hungary, used a laboratory model to mimic the acidic environment of the human stomach. Molnar and his colleagues found that when lutein is taken in the unesterified or ‘free’ form, it is more prone to degradation in the stomach, which means that the amount reaching the intestine for absorption into the bloodstream is likely to be reduced.1 They explain: “It is predicted on the basis of these results that only ingested lutein ester (fruits, dietary supplements) reaches the intestinal tract intact, whilst a large proportion of ingested unesterified lutein (green vegetables, dietary supplements) is decomposed before reaching the intestinal absorption sites. Results from the second study, published recently in Experimental Eye Research, showed that a daily supplement of 12 mg lutein from Xangold(R) natural lutein esters increases macular pigment density in adults with early-stage Age-related Macular Degeneration (AMD). The so-called LUNA study was conducted by ophthalmologist Dr. Meike Trieschmann, who said: “A significant augmentation of macular pigment density was found in a majority of study subjects, including those afflicted with AMD. The importance of these findings rests on the fact that the beneficial effects of these antioxidants can also be extended to subjects with established disease.” 2 The food supplement used in the study consisted of 12 mg lutein and 1 mg zeaxanthin, both provided in the ester form as Xangoldâ, 120 mg vitamin C, 17.6 mg vitamin E, 10 mg zinc and 40 µg selenium. Dr. Holger Becker commented: “These two studies add significant new data to the already substantial body of evidence that supports Xangoldâ natural lutein esters. They endorse our claim that Xangoldâ offers customers the gold standard for success in the growing eye health category.” 1 Molnar P et al., In vitro degradation of lutein but not lutein ester by gastric pH. Carotenoid Science 2006;10:1-5. The study was a direct comparison of lutein esters (76% lutein ester extract, INEXA) and free lutein (prepared from lutein esters by saponification based on previously published methods, Molnar et al 1979). 2 Trieschmann, M. et al., Changes in macular pigment optical density and serum concentrations of its constituent carotenoids following supplemental lutein and zeaxanthin: The LUNA study, Exp. Eye. Res. 2007;84:718-728 About Cognis: Cognis is a worldwide supplier of innovative specialty chemicals and nutritional ingredients. The company employs about 8,000 people, and it operates production sites and service centers in 30 countries. Cognis has dedicated its activities to a high level of sustainability and delivers natural source raw materials and ingredients for food, nutrition and healthcare markets, and the cosmetics, detergents and cleaners industries. Another main focus is on products for a number of other industries, such as coatings and inks, lubricants, textiles, as well as agriculture and mining. The company holds a 50-percent stake in the joint venture Cognis Oleochemicals, one of the world’s leading manufacturers of natural-source oleochemical basestocks. Cognis is owned by private equity funds advised by Permira, GS Capital Partners, and SV Life Sciences. In 2006, Cognis recorded sales of 3.37 billion euros and an Adjusted EBITDA (operating result) of 394 million euros.
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software